Diseases /

Acute Myeloid Leukemia Not Otherwise Specified

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: Acute myeloid leukemias that do not fulfill the criteria for inclusion in the group of acute myeloid leukemias which have recurrent genetic abnormalities or myelodysplastic changes, or are therapy-related. This category includes entities classified according to the French-American-British classification scheme. [1]

Clinical Trials

View Clinical Trials for Acute Myeloid Leukemia Not Otherwise Specified

Disease Details

Synonyms
Acute Myeloid Leukemia NOS, Acute Myeloid Leukemia Not Otherwise Categorized, AML, NOS, Acute Myeloid Leukemia, NOS, Acute myeloid leukemia, Acute myeloid leukemia (AML) (NOS), PEDIATRIC Acute myeloid leukemia (AML) (NOS)
Parent(s)
Acute Myeloid Leukemia
Children
Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia with Maturation, Acute Myeloid Leukemia without Maturation, Acute Panmyelosis with Myelofibrosis, Acute Myelomonocytic Leukemia, Acute Monoblastic and Monocytic Leukemia, Acute Basophilic Leukemia, and Acute Myeloid Leukemia with Minimal Differentiation
OncoTree Name
AML, NOS
OncoTree Code
AMLNOS

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.